Singapore Market Roundup (10-Sep-2026): RHB views Raffles Medical's 52-week low as a buy signal.
RHB views Raffles Medical's 52-week low as a buying chance. Citi gives a 'buy/high risk' rating to CSE Global, while Maybank's Seet is bullish on...
116 Views
Singapore Market Roundup (09-Sep-2026): Maybank's Seet lowers Frencken target price after $100M
Maybank's Seet remains positive on Frencken despite lowering the target price after a $100M placement. UOBKH cuts Delfi's target price amid cocoa...
115 Views
Singapore Market Roundup (27-Aug-2026): CLSA rates Addvalue 'outperform,' with a TP of 27 cents.
CLSA rates Addvalue as 'high-conviction outperform' with a target price of 27 cents. UOBKH raises Pan-United's target to $1.88, maintaining 'buy'....
127 Views
Singapore Market Roundup (26-Aug-2026): UOB Kay Hian downgrades DBS to 'hold', maintains 'buy' on
UOB Kay Hian downgrades DBS to 'hold', maintains 'buy' on OCBC. Huationg's target price cut to 88 cents; Nam Cheong remains 'buy' at $2.05 target.
164 Views
Singapore Market Roundup (25-Aug-2026): BRC Asia gets positive outlook from PhillipCapital, CGSI,
PhillipCapital, CGSI, and UOBKH are bullish on BRC Asia. OCBC Research initiates 'buy' on Foundation Healthcare, and RHB maintains 'buy' on Delfi...
110 Views